60 Degrees Pharmaceuticals, Inc.
SXTP
$1.41
$0.118.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 20.13% | -1.95% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 20.13% | -1.95% | |||
| Cost of Revenue | -37.64% | 146.82% | |||
| Gross Profit | 103.52% | -117.43% | |||
| SG&A Expenses | -4.36% | 5.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.74% | -7.28% | |||
| Operating Income | 16.02% | 7.94% | |||
| Income Before Tax | 7.66% | 8.40% | |||
| Income Tax Expenses | 1,400.00% | 120.00% | |||
| Earnings from Continuing Operations | 7.59% | 8.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 50.00% | -79.49% | |||
| Net Income | 7.61% | 8.24% | |||
| EBIT | 16.02% | 7.94% | |||
| EBITDA | 16.31% | 8.05% | |||
| EPS Basic | 18.73% | 31.73% | |||
| Normalized Basic EPS | 19.58% | 31.62% | |||
| EPS Diluted | 18.73% | 31.73% | |||
| Normalized Diluted EPS | 19.58% | 31.62% | |||
| Average Basic Shares Outstanding | 14.76% | 34.29% | |||
| Average Diluted Shares Outstanding | 14.76% | 34.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||